Explore how hybrid biomaterial scaffolds with controlled factor delivery are revolutionizing cardiovascular tissue engineering and heart repair.
Breakthrough research on using engineered Treg cells to target and treat atherosclerosis, the leading cause of cardiovascular disease worldwide.